Sharpe ratio is not yet available for HOLX. This metric requires at least 12 months of historical daily returns to calculate. Check back once this data is available.
How it compares to other similar stocks
The table compares Hologic, Inc.'s Sharpe Ratio with other stocks in the Medical Instruments & Supplies industry across multiple time periods, showing how HOLX's risk-adjusted performance compares to industry peers.
Data shows 1-, 5-, and 10-year periods, plus each stock's all-time average, as of Jun 5, 2026.
| Symbol | Name | 1Y Sharpe Ratio | 5Y Sharpe Ratio | 10Y Sharpe Ratio | All Time Sharpe Ratio |
|---|---|---|---|---|---|
| NNNN | Anbio Biotechnology Class A | 1.44 | |||
| HOCPY | Hoya Corp | 1.33 | |||
| AVR | Anteris Technologies Global Corp | 1.30 | |||
| WST | West Pharmaceutical Services, Inc. | 1.23 | |||
| STAA | STAAR Surgical Company | 1.15 | |||
| BLCO | Bausch + Lomb Corp | 1.07 | |||
| UTMD | Utah Medical Products, Inc. | 1.02 | |||
| PDEX | Pro-Dex, Inc. | 0.97 | |||
| INFU | InfuSystem Holdings Inc. | 0.93 | |||
| OSUR | OraSure Technologies, Inc. | 0.91 | |||
| HOLX | Hologic, Inc. | — |
Loading charts...
Sharpe Ratio Calculator
How does HOLX fit in your portfolio?
Add your other holdings to see your portfolio's Sharpe Ratio and find out.
Analyze Your Portfolio